Salvacion Gatchalian

1.3k total citations
39 papers, 914 citations indexed

About

Salvacion Gatchalian is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, Salvacion Gatchalian has authored 39 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 13 papers in Infectious Diseases and 10 papers in Microbiology. Recurrent topics in Salvacion Gatchalian's work include Pneumonia and Respiratory Infections (17 papers), Influenza Virus Research Studies (11 papers) and Bacterial Infections and Vaccines (10 papers). Salvacion Gatchalian is often cited by papers focused on Pneumonia and Respiratory Infections (17 papers), Influenza Virus Research Studies (11 papers) and Bacterial Infections and Vaccines (10 papers). Salvacion Gatchalian collaborates with scholars based in Philippines, Belgium and United States. Salvacion Gatchalian's co-authors include Lulu Muhe, Deborah Lehmann, John B. Carlin, Kim Mulholland, Lode Schuerman, Nancy Bermal, E. Kim Mulholland, Frank E. Harrell, Heinz F. Eichenwald and Karen Mason and has published in prestigious journals such as Emerging infectious diseases, Statistics in Medicine and Vaccine.

In The Last Decade

Salvacion Gatchalian

39 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Salvacion Gatchalian Philippines	16	555	254	247	198	95	39	914
Svein Arne Nordbø Norway	24	908 1.6×	238 0.9×	745 3.0×	145 0.7×	55 0.6×	83	1.7k
Najwa Khuri‐Bulos Jordan	22	681 1.2×	132 0.5×	459 1.9×	116 0.6×	88 0.9×	71	1.3k
M. C. Steinhoff United States	25	1.4k 2.4×	433 1.7×	395 1.6×	183 0.9×	64 0.7×	60	1.7k
Claudia Tagliabue Italy	27	1.2k 2.1×	209 0.8×	463 1.9×	118 0.6×	59 0.6×	60	1.7k
P Bègué France	16	668 1.2×	537 2.1×	204 0.8×	139 0.7×	102 1.1×	140	1.2k
Jay M. Lieberman United States	20	676 1.2×	279 1.1×	516 2.1×	181 0.9×	79 0.8×	31	1.2k
María L. Ávila-Agüero Costa Rica	20	493 0.9×	240 0.9×	267 1.1×	157 0.8×	38 0.4×	86	1.1k
Taj Jadavji Canada	18	634 1.1×	391 1.5×	242 1.0×	194 1.0×	34 0.4×	56	1.1k
Ángela Gentile Argentina	19	822 1.5×	395 1.6×	335 1.4×	84 0.4×	63 0.7×	119	1.3k
Beverly L. Connelly United States	20	588 1.1×	158 0.6×	164 0.7×	70 0.4×	39 0.4×	33	1.1k

Countries citing papers authored by Salvacion Gatchalian

Since Specialization

Citations

This map shows the geographic impact of Salvacion Gatchalian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvacion Gatchalian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvacion Gatchalian more than expected).

Fields of papers citing papers by Salvacion Gatchalian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvacion Gatchalian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvacion Gatchalian. The network helps show where Salvacion Gatchalian may publish in the future.

Co-authorship network of co-authors of Salvacion Gatchalian

This figure shows the co-authorship network connecting the top 25 collaborators of Salvacion Gatchalian. A scholar is included among the top collaborators of Salvacion Gatchalian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvacion Gatchalian. Salvacion Gatchalian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Murray, Kristy O., et al.. (2019). Prevalence of Tuberculosis in Children After Natural Disasters, Bohol, Philippines. Emerging infectious diseases. 25(10). 1884–1892. 8 indexed citations

2.

Montoya, Jaime, Juan Antonio Solon, Luz P. Acosta, et al.. (2013). A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults. Journal of Clinical Immunology. 33(8). 1360–1375. 64 indexed citations

3.

Quiambao, Beatriz P., et al.. (2012). A randomized, dose-ranging assessment of the immunogenicity and safety of a booster dose of a combined diphtheria-tetanus-whole cell pertussis-hepatitis B-inactivated poliovirus-Hemophilus influenzaetype b (DTPw-HBV-IPV/Hib) vaccine vs. co-administration of DTPw-HBV/Hib and IPV vaccines in 12 to 24 months old Filipino toddlers. Human Vaccines & Immunotherapeutics. 8(3). 347–354. 9 indexed citations

4.

Anh, Đặng Đức, Celia Carlos, Yanee Hutagalung, et al.. (2011). Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix™) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006–2007. Vaccine. 29(11). 2029–2036. 30 indexed citations

5.

Memish, Ziad A., Ghassan Dbaibo, May Montellano, et al.. (2011). Immunogenicity of a Single Dose of Tetravalent Meningococcal Serogroups A, C, W-135, and Y Conjugate Vaccine Administered to 2- to 10-year-olds Is Noninferior to a Licensed-ACWY Polysaccharide Vaccine With an Acceptable Safety Profile. The Pediatric Infectious Disease Journal. 30(4). e56–e62. 46 indexed citations

6.

Gatchalian, Salvacion, Gunasekaran Ramakrishnan, Hans L. Bock, Inge Lefevre, & Jeanne‐Marie Jacquet. (2010). Immunogenicity, reactogenicity and safety of three-dose primary and booster vaccination with combined diphtheria-tetanus-whole-cell pertussis-hepatitis B-reduced antigen contentHaemophilus influenzaetype b vaccine in Filipino children. Human Vaccines. 6(8). 664–672. 3 indexed citations

7.

Bermal, Nancy, Leszek Szenborn, Edison Alberto, et al.. (2010). SAFETY AND IMMUNOGENICITY OF A BOOSTER DOSE OF THE 10-VALENT PNEUMOCOCCAL NONTYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D CONJUGATE VACCINE COADMINISTERED WITH DTPW-HBV/HIB AND POLIOVIRUS VACCINES. The Pediatric Infectious Disease Journal. 30(1). 69–72. 26 indexed citations

8.

Gatchalian, Salvacion, Lei Zhang, Sutee Yoksan, et al.. (2008). Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants. Vaccine. 26(18). 2234–2241. 37 indexed citations

9.

Hausdorff, William P., F. Beckers, Ron Dagan, et al.. (2008). Impact Estimate of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D-Conjugate Vaccine (PHiD-CV) on Invasive Pneumococcal Disease (IPD) in Middle East and Asian Countries. International Journal of Infectious Diseases. 12. e44–e45. 1 indexed citations

10.

Bermal, Nancy, et al.. (2008). Antibody Responses Following Administration of 10-Valent Pneumococcal Non-Typeable Haemophilus influenzas Protein D-Conjugate Vaccine (PHiD-CV) in Filipino Infants. International Journal of Infectious Diseases. 12. e44–e44. 1 indexed citations

11.

Gatchalian, Salvacion, Nancy Bermal, Vijayalakshmi Chandrasekaran, et al.. (2008). A new DTPw-HBV/Hib vaccine: Immune memory after primary vaccination and booster dosing in the second year of life. Human Vaccines. 4(1). 60–66. 7 indexed citations

12.

Kerdpanich, Angkool, Boonyarat Warachit, Salvacion Gatchalian, et al.. (2007). Primary vaccination with a new heptavalent DTPw–HBV/Hib–Neisseria meningitidis serogroups A and C combined vaccine is well tolerated. International Journal of Infectious Diseases. 12(1). 88–97. 7 indexed citations

13.

Gatchalian, Salvacion, Inge Lefevre, Marie‐Pierre David, et al.. (2005). A New DTPw-HBV/Hib Vaccine is Immunogenic and Safe when Administered According to the EPI (Expanded Programme for Immunization) Schedule and Following Hepatitis B Vaccination at Birth. Human Vaccines. 1(5). 198–203. 32 indexed citations

14.

Palmer, Ayo, John B. Carlin, Joachim Freihorst, et al.. (2004). The use of CRP for diagnosing infections in young infants < 3 months of age in developing countries. Annals of Tropical Paediatrics. 24(3). 205–212. 12 indexed citations

15.

Carlin, John B., et al.. (2003). Predictors of neonatal sepsis in developing countries. The Pediatric Infectious Disease Journal. 22(8). 711–717. 108 indexed citations

16.

Gatchalian, Salvacion, et al.. (1999). Bacterial and viral etiology of serious infections in very young Filipino infants. The Pediatric Infectious Disease Journal. 18(Supplement). 50S–55S. 36 indexed citations

17.

Weber, Martin W., Salvacion Gatchalian, Arnold L. Smith, et al.. (1999). Chloramphenicol pharmacokinetics in infants less than three months of age in the Philippines and The Gambia. The Pediatric Infectious Disease Journal. 18(10). 896–901. 6 indexed citations

18.

Harrell, Frank E., Peter A. Margolis, S Gove, et al.. (1998). Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological Agents of Pneumonia, Sepsis and Meningitis in Young Infants. Statistics in Medicine. 17(8). 909–944. 8 indexed citations

19.

Quiambao, Beatriz P., Salvacion Gatchalian, Pekka Halonen, et al.. (1998). Coinfection is common in measles-associated pneumonia. The Pediatric Infectious Disease Journal. 17(2). 89–93. 30 indexed citations

20.

Harrell, Frank E., Peter A. Margolis, S Gove, et al.. (1998). Development of a clinical prediction model for an ordinal outcome: the World Health Organization Multicentre Study of Clinical Signs and Etiological Agents of Pneumonia, Sepsis and Meningitis in Young Infants. Statistics in Medicine. 17(8). 909–944. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact